UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): July 14, 2014


PetMed Express, Inc.
(Exact name of registrant as specified in its charter)



Florida

 

000-28827

 

65-0680967

(State or other jurisdiction
of incorporation)

 

(Commission
File Number)

 

(I.R.S. Employer
Identification No.)


1441 S.W. 29th Avenue,  Pompano Beach, FL  33069

(Address of principal executive offices) (Zip Code)


(954) 979-5995

(Registrant’s telephone number, including area code)


Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))








Item 8.01   Other Events.


On July 14, 2014, PetMed Express, Inc. issued a press release stating that it will announce its June 30, 2014 quarter-end financial results and host a conference call to review the results on Monday, July 21, 2014.  A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01   Financial Statements and Exhibits.


 

(d)

Exhibits.

 

 

 

 

 

99.1 – Press release dated July 14, 2014.

EXHIBIT INDEX


Exhibit No.

 

Description

 

 

 

99.1

 

Press release dated July 14, 2014.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: July 16, 2014


 

PETMED EXPRESS, INC.

 

 

 

 

By:

/s/ Bruce S. Rosenbloom

 

Name:

Bruce S. Rosenbloom

 

Title:

Chief Financial Officer

 

 

 

2











 

Exhibit 99.1

 

PETMED EXPRESS D/B/A 1-800-PETMEDS TO ANNOUNCE ITS FIRST QUARTER FINANCIAL RESULTS ON JULY 21, 2014

 

Pompano Beach, Florida, July 14, 2014 - PetMed Express, Inc. (NASDAQ: PETS) will announce its financial results for the quarter ended June 30, 2014 on Monday, July 21, 2014 at 8:00 A.M. Eastern Time, then at 8:30 A.M. Eastern Time, Menderes Akdag, the Company’s Chief Executive Officer and President, will host a conference call to review the financial results.


To access the call, which is open to the public, please dial (888) 455-1758 (toll free) or (203) 827-7025, ten minutes prior to the scheduled start time.  Callers will be required to supply PETMEDS as the passcode, and will be placed on hold with music until the call begins.


For those unable to participate in the live event, the call will be available for replay from    10:00 A.M. on July 21, 2014 until August 4, 2014 at 11:59 P.M.  To access the replay, call (866) 509-3896 (toll free) or (203) 369-1915, and enter passcode 5500.


Founded in 1996, PetMed Express is America’s Largest Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com.


This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan.  Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2014.  The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.


For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 954-979-5995.


###


Exhibit 99.1 Page 1 of 1











PetMed Express (NASDAQ:PETS)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more PetMed Express Charts.
PetMed Express (NASDAQ:PETS)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more PetMed Express Charts.